Post discharge clinically overt venous thromboembolism in orthopaedic surgery patients with negative venography - An overview analysis

Thrombosis and Haemostasis

Volumn 76, Issue 6, 1996, Pages 887-892

  Ricotta, Serena ^a   Iorio, Alfonso ^a   Parise, Pasquale ^a   Nenci, Giuseppe G ^a   Agnelli, Giancarlo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DALTEPARIN; DANAPAROID; DERMATAN SULFATE; DEXTRAN; ENOXAPARIN; HEPARIN; NADROPARIN; TINZAPARIN; WARFARIN;

ARTICLE; CLINICAL TRIAL; FOLLOW UP; HUMAN; INCIDENCE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; ORTHOPEDIC SURGERY; PHLEBOGRAPHY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; VEIN THROMBOSIS;

EID: 0030442462     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1650681     Document Type: Article

References (56)

1. Salzman EW, Hirsh J. The epidemiology, pathogenesis and natural history of venous thrombosis. In: Haemostasis and Thrombosis. Basic Principles and Clinical Practice. Colman RW, Hirsh J, Marder VJ, Salzman EW, eds. Philadelphia, PA: JB Lippincott Company 1994; 1275-96.
2. Collins R, Scrimigeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopaedic and urologic surgery. N Engl J Med 1988; 318: 1162-73.
3. Gallus AS, Salzman EW, Hirsh J. Prevention of venous thromboembolism. In: Haemostasis and Thrombosis. Basic Principles and Clinical Practice. Colman RW, Hirsh J, Marder VJ, Salzman EW, eds. Philadelphia, PA: JB Lippincott Company 1994; 1331-45.
4. Agnelli G, Radicchia S, Nenci GG. The diagnosis of deep vein thrombosis in asymptomatic high risk patients. Haemostasis 1995; 25: 40-8.
5. Agnelli G, Ranucci V, Veschi F, Rinonapoli E, Lupattelli L, Nenci GG. Clinical outcome of hip surgery patients with negative lower limb venography at discharge. Thromb Haemost 1995; 74: 1042-4.
6. Altman DG. Practical statistics for medical research. London: Chapman and Hall 1991; 230.
7. Evarts CM, Alfidi RJ. Thromboembolism after total hip reconstruction; Failure of low doses of heparin in prevention. JAMA 1973; 225: 515-6.
8. Harris WH, Salzman EW, Athanasoulis C, Waltman AC, Baum S, DeSanctis RW. Comparison of warfarin, low-molecular-weight dextran, aspirin, and subcutaneous heparin in prevention of venous thromboembolism following total hip replacement. J Bone Joint Surg 1974; 56: 1552-62.
9. Moskovitz PA, Ellemberg SS, Feffer HL, Kenmore PI, Neviaser RJ, Rubin BE, Varma VM. Low dose heparin for prevention of venous thromboembolism in total hip arthroplasty and surgical repair of hip fractures. J Bone Joint Surg 1978; 60: 1065-70.
10. Rogers PH, Walsh PN, Marder VJ, Bosak GC, Lachman JW, Ritchie WGM, L Oppenheimer, S Sherry. Controlled trial of low dose heparin and sulfinpyrazone to prevent venous thromboembolism after operation on the hip. J Bone Joint Surg 1978; 60: 758-62.
11. Sautter RD, Koch EL, Myers WO, Ray J R, Mazza JJ, Larson DE. Aspirinsulfinpyrazone in prophylaxis of deep venous thrombosis in total hip replacement. JAMA 1983; 250: 2649-54.
12. Turpie AG, Levine MN, Hirsh J, Carter CJ, Jay RM, Powers PJ, Andrew M, Hull RD, Gent M. A randomized controlled trial of a low molecular weight heparin (enoxaparin) to prevent deep vein thrombosis in patients undergoing elective hip surgery. N Engl J Med 1986; 315: 925-9.
13. Planès A, Vochelle N, Mazas F, Mansat C, Zucman J, Landais A, Pascariello JC, Weill D, Butel J. Prevention of postoperative venous thrombosis: a randomized trial comparing unfractionated heparin with low molecular weight in patients undergoing total hip replacement. Thromb Haemost 1988; 60: 407-10.
14. Dechavanne M, Ville D, Berruyer, Trepo F, Dalery F, Clermont N, Lerat JL, Moyen B, Fisher LP, Kher A, Barbier P. Randomized trial of a low molecular weight heparin (Kabi2165) versus adjusted dose subcutaneous standard heparin in the prophylaxis of deep vein thrombosis after elective hip surgery. Haemostasis 1989; 1: 5-12.
15. Francis CW, Pellegrini VD, Marder VJ, Harris CM, Totterman S, Gabriel KR, Baughman DJ, Roemer S, Burke J, Goodman TL, Evarts CMC. Prevention of venous thrombosis after total hip arthroplasty. J Bone Joint Surg 1989; 71: 327-35.
16. Sharrock NE, Brien WW, Salvati EA, Mineo R, Garvin K, Sculco TP. The effect of intravenous fixed-dose heparin during total hip arthroplasty on the incidence of deep-vein thrombosis. J Bone Joint Surg 1990; 72: 1456-61.
17. Eriksson BI, Kälebo P, Anthmyr A, Wadenvik H, Tengborn L, Risberg B. Prevention of deep-vein thrombosis and pulmonary embolism after total hip replacement. J Bone Joint Surg 1991; 73: 484-93.
18. Lassen MR, Borris LC, Christiansen HM, Boll KL, Eiskjaer SP, Nielsen BW, Schott P, Olsen AD, Rodenberg JC, Lucht U. Prevention of thromboembolism in 190 hip arthroplasties; Comparison of low-molecular weight heparin and placebo. Acta Orthop Scand 1991; 62: 33-8.
19. Borris LC, Soresen JV. Components of coagulation and fibrinolysis during thrombosis prophylaxis with a low molecular weight heparin versus dextran 70 in hip arthroplasty. Thromb Res 1991; 63: 21-8.
20. Levine M, Hirsh J, Gent M, Turpie AG, Leclerc J, Powers PJ, Jay RM, Neemeh J. Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin. Ann Intern Med 1991; 114: 545-51.
21. Bergqvist D, Kettunen K, Fredin H, Fauno P, Suomalainen O, Soimakallio S, Karjalainen P, Cederholm C, Jensen LJ, Justesen T, Stiekema JCJ. Thromboprophylaxis in patients with hip fractures: A prospective, randomized, comparative study between Org 10172 and dextran 70. Surgery 1991; 109: 617-22.
22. Hoek JA, Nurmohamed MT, Hamelynck KJ, Marti RK, Knipscheer HC, ten Cate H, Büller HR, Magnani HN, ten Cate JW. Prevention of deep vein thrombosis following total hip replacement by low molecular weight heparinoid. Thromb Haemost 1992; 67: 28-32.
23. Leclerc JR, Geerts WH, Desjardins L, Jobin F, Laroche F, Delorme F, Haviernick S, Atkinson S, Bourgouin J. Prevention of deep vein thrombosis after major knee surgery. A randomized, double blind trial comparing a low molecular weight heparin fragment (Enoxaparin) to placebo. Thromb Haemost 1992; 67: 417-23.
24. The German Hip Arthroplasty Trial (GHAT) Group. Prevention of deep vein thrombosis with low molecular weight heparin in patients undergoing total hip replacement. A randomized trial. Arch Orthop Surg 1992; 111: 110-20.
25. Agnelli G, Cosmi B, Di Filippo P, Ranucci V, Veschi F, Longetti M, Renga C, Barzi F, Gianese F, Lupattelli L, Rinonapoli E, Nenci GG. A randomised, double-blind, placebo-controlled trial of deramtan sulfate for prevention of deep vein thrombosis in hip fracture. Thromb Haemost 1992; 67: 203-8.
26. Hull R, Raskob G, Pineo G, Rosembloom D, Evans W, Mallory T, Anquist K, Smith F, Hughes G, Green D, Elliott CG, Panju A, Brant R. A comparison of subcutaneous low molecular weight heparin with warfarin sodium for prophylaxis against deep vein thrombosis after hip or knee implantation. N Engl J Med 1993; 329: 1370-5.
27. Hoffman R, Kohler A, Platz A, Raggo A, Bischof Th., Von Felten A. Prevention of deep vein thrombosis (DVT) in hip surgery: low molecular weight heparin (Sandoparin) versus 3 X 5000 unfractionated heparin. A Randomized prospective study. Thromb Haemost 1993; 69: 1055.
28. Weber U, Koppenhagen M, Matthes M, Ludewig S. Differents effects of low molecular weight heparin in total hip replacement. Thromb Haemost 1993; 69: 1117.
29. Kalodiki E, N Nicolaides, AI-Kutoubi A, Birch R, Harris N, Hunt D, Johnson J, Marx C. LMWH and LMWH plus graduate elastic compression for DVT prophylaxis in total hip replacement. Thromb Haemost 1993; 69: 619.
30. Powers P, Gent M, Klimek M, Levine M, Geerts, Neemeh J, Turpie AGG, Jay R, Leclerc J, Ginsberg J, Hirsh J. A randomized double blind trial comparing a low molecular weight heparinoid, orgaran, with aspirin in the prevention of venous thromboembolism following surgery for hip fracture. Thromb Haemost 1993; 69: 1116.
31. Planes A. A comparison of antithrombotic efficacy and haematologic side-effects of clivarin versus enoxaparin in patients undergoing total hip replacement surgery. Blood Coag Fibrinol 1993; 1: S33-S35.
32. Fauno P, Suomalainen O, Rehnberg V, Hansen TB, Kroner K, Soimakallio S, Katila T, Hansen BR, Nielsen E, Albrechtsen J. Thromboembolic prophylaxis in total knee replacement patients. An evaluation of two different regimens. Thromb Haemost 1993; 69: 1055.
33. Bradley JG, Krugener GH, Jager HJ. The effectivness of intermittent plantar venous compression in prevention of deep venous thrombosis after total hip surgery. J Arthroplasty 1993; 8: 57-61.
34. Cohen AT, Phillips MJ, Edmondson RA, Skinner JA, Das SK, Cooper DJ, Thomas EM, Melissari E, Kakkar V. A dose ranging study to evaluate dermatan sulphate in preventing deep vein thrombosis following total hip arthroplasty. Thromb Haemost 1994; 72: 793-8.
35. Spiro TE, Johnson GJ, Christie MJ, Lyons RM, MacFarlane DE, Blasier RB, Tremaine MD, Efficacy and safety of Enoxaparin to prevent deep vein thrombosis after hip replacement surgery. Ann Intern Med 1994; 121: 81-9.
36. Trowbridge A, Boese CK, Woodruff B, Brindley HH, Lowry WE, Spiro TE. Incidence of posthospitalization proximal deep venous thrombosis after total hip arthroplasty. Clin Orthop Rel Res 1994; 299: 203-8.
37. Agnelli G, Damiani M, Veschi F, Cosmi F, Nenci GG, Pattacini C, Pini M. A double blind randomised trial on Organon versus unfractionated heparin in the prevention of deep vein thrombosis after elective hip replacement. Thromb Haemost 1995; 73: 1103.
38. Bergqvist D. Long-Term Prophylaxis following Orthopedic Surgery. Haemostasis 1993; 23: 27-31.
39. Sevitt S, Gallagher NG. Prevention of venous thrombosis and pulmonary embolism in injured patients. A trial of anticoagulant prophylaxis with phenindione in middle-aged and elderly patients with fractured necks of femur. Lancet 1959; ii: 981-9.
40. Clarke-Pearson DL, Jelovsek FR, Creasman WT. Thromboembolism complicating surgery for cervical and uterine malignancy: incidence, risk factors, and prophylaxis. Obstet Gynecol 1983; 61: 87-94.
41. Clarke-Pearson DL, Synan IS, Coleman RE, Hinshaw W, Creasman WT. The natural history of postoperative venous thromboembolism in gynecologic oncology: a prospective study of 382 patients. Am J Obstet Gynecol 1984; 148: 1051-4.
42. Scurr JH, Coleridge Smith PD, Hasty JH. Deep venous thrombosis: a continuing problem. Br Med J 1988; 297: 28.
43. Huber O, Bounameaux H, Borst F, Rohner A. Postoperative embolism after hospital discharge. An underestimated risk. Arch Surg 1992; 127: 310-3.
44. Seagroatt V, Tan HS, Goldacre M, Bulatrode C, Nugent I, Gill L. Elective total hip replacement: incidence, emergency readmission rate and postoperative mortality. Br Med J 1991; 303: 1431-5.
45. Tremaine MD, Choroszy CJ, Menking SA. Deep vein thrombosis in the total hip arthroplasty patient after hospital discharge. J Vasc Technology 1991; 15: 205-6.
46. Warwick D, Williams MH, Bannister GC. Death and thromboembolic disease after total hip replacement. A series of 1162 cases with no routine chemical prophylaxis. J Bone Joint Surg 1995; 77-B: 6-10.
47. Amstutz HC, Frisene DA, Dorey F, Carmey BT. Warfarin prophylaxis to prevent mortality from pulmonary embolism after total hip replacement. J Bone Joint Surg 1989; 71A: 742-7.
48. Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, Kelton JG. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995; 332: 1330-5.
49. 125I labelled fibrinogen. Br J Surg 1968; 55: 742-7.
50. Westerman K, Trentz O, Pretschner, Mellmann J. Thromboembolism after hip surgery. Int Orthop 1981; 4: 253-8.
51. Planès A, Vochelle N, Darmon JY, Fagola M, Bellaud M, Huet Y. Risk of deep venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo. Lancet 1996; 348: 224-8.
52. ten Cate JW, Prins MH. Major orthopaedic surgery and post-discharge DVT. Lancet 1996; 348: 209-10.
53. Agnelli G, Cosmi B, Ranucci, Renga C, Mosca S, Lupattelli L, Di Filippo P, Rinonapoli E, Nenci GG. Impedance plethysmography in the diagnosis of asymptomatic deep vein thrombosis in hip surgery. A venography controlled study. Arch Int Med 1991; 151: 2167-71.
54. 125I-fibrinogen leg scanning: reassessment of its role for the diagnosis of venous thrombosis in post-operative patients. Thromb Haemost 1993; 69: 2-7.
55. Agnelli G, Volpato R, Radicchia S, Veschi F, Di Filippo P, Lupattelli L, Nenci GG. Detection of asymptomatic deep vein thrombosis by real-time B-mode ultrasonography in hip surgery patients. Thromb Haemost 1992; 68: 257-60.
56. Agnelli G, Cosmi B, Radicchia S, Veschi F, Boschetti E, Lupattelli L, Rinonapoli E, Nenci GG. Features of thrombi and diagnostic accuracy of impedance plethysmography in symptomatic and asymptomatic deep vein thrombosis. Thromb Haemost 1993; 70: 266-9.